The infusion of $6 million accelerates CustoMED’s rollout of personalized orthopedic implants, positioning it to capture market share as hospitals adopt AI tools, and signals strong investor confidence in med‑tech AI innovation.
CustoMED, an Israel-based developer of AI-driven, surgeon-first platforms for patient-specific orthopedic solutions, closed a $6M seed round led by a syndicate including Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority and Avishai Abrahami. The company will use the proceeds to expand its platform and operations.
Comments
Want to join the conversation?
Loading comments...